203 related articles for article (PubMed ID: 18393288)
81. Cytoskeletal requirements for hepatitis C virus (HCV) RNA synthesis in the HCV replicon cell culture system.
Bost AG; Venable D; Liu L; Heinz BA
J Virol; 2003 Apr; 77(7):4401-8. PubMed ID: 12634397
[TBL] [Abstract][Full Text] [Related]
82. An in vitro model of hepatitis C virion production.
Heller T; Saito S; Auerbach J; Williams T; Moreen TR; Jazwinski A; Cruz B; Jeurkar N; Sapp R; Luo G; Liang TJ
Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2579-83. PubMed ID: 15701697
[TBL] [Abstract][Full Text] [Related]
83. Use of proteomic analysis tools to identify HCV-proteins down-regulated by acetylsalicylic acid.
Sánchez-García A; Ríos-Ibarra CP; Rincón-Sánchez AR; Ortiz-López R; Garza-Juárez A; Morlett-Chávez J; Martínez-Rodríguez H; Rivas-Estilla AM
Ann Hepatol; 2013; 12(5):725-32. PubMed ID: 24018490
[TBL] [Abstract][Full Text] [Related]
84. SEC14L2, a lipid-binding protein, regulates HCV replication in culture with inter- and intra-genotype variations.
Costa R; Todt D; Zapatero-Belinchón F; Schenk C; Anastasiou OE; Walker A; Hertel B; Timmer L; Bojkova D; Ruckert M; Sarrazin C; Timm J; Lohmann V; Manns MP; Steinmann E; von Hahn T; Ciesek S
J Hepatol; 2019 Apr; 70(4):603-614. PubMed ID: 30472319
[TBL] [Abstract][Full Text] [Related]
85. Effects of the Mammalian Target of Rapamycin Inhibitor Everolimus on Hepatitis C Virus Replication In Vitro and In Vivo.
Frey A; Ecker EM; Piras-Straub K; Walker A; Hofmann TG; Timm J; Singer BB; Gerken G; Herzer K
Transplant Proc; 2017 Oct; 49(8):1947-1955. PubMed ID: 28923653
[TBL] [Abstract][Full Text] [Related]
86. Tannic Acid Inhibits Hepatitis C Virus Entry into Huh7.5 Cells.
Liu S; Chen R; Hagedorn CH
PLoS One; 2015; 10(7):e0131358. PubMed ID: 26186636
[TBL] [Abstract][Full Text] [Related]
87. New 1-phenyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides inhibit hepatitis C virus replication via suppression of cyclooxygenase-2.
Manvar D; Pelliccia S; La Regina G; Famiglini V; Coluccia A; Ruggieri A; Anticoli S; Lee JC; Basu A; Cevik O; Nencioni L; Palamara AT; Zamperini C; Botta M; Neyts J; Leyssen P; Kaushik-Basu N; Silvestri R
Eur J Med Chem; 2015 Jan; 90():497-506. PubMed ID: 25483263
[TBL] [Abstract][Full Text] [Related]
88. Alcohol facilitates HCV RNA replication via up-regulation of miR-122 expression and inhibition of cyclin G1 in human hepatoma cells.
Hou W; Bukong TN; Kodys K; Szabo G
Alcohol Clin Exp Res; 2013 Apr; 37(4):599-608. PubMed ID: 23126531
[TBL] [Abstract][Full Text] [Related]
89. Effect of cell growth on hepatitis C virus (HCV) replication and a mechanism of cell confluence-based inhibition of HCV RNA and protein expression.
Nelson HB; Tang H
J Virol; 2006 Feb; 80(3):1181-90. PubMed ID: 16414995
[TBL] [Abstract][Full Text] [Related]
90. San-Huang-Xie-Xin-Tang extract suppresses hepatitis C virus replication and virus-induced cyclooxygenase-2 expression.
Lee JC; Tseng CK; Wu SF; Chang FR; Chiu CC; Wu YC
J Viral Hepat; 2011 Jul; 18(7):e315-24. PubMed ID: 21692943
[TBL] [Abstract][Full Text] [Related]
91. Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation.
Ye J; Wang C; Sumpter R; Brown MS; Goldstein JL; Gale M
Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15865-70. PubMed ID: 14668447
[TBL] [Abstract][Full Text] [Related]
92. Enhancement of internal ribosome entry site-mediated translation and replication of hepatitis C virus by PD98059.
Murata T; Hijikata M; Shimotohno K
Virology; 2005 Sep; 340(1):105-15. PubMed ID: 16005928
[TBL] [Abstract][Full Text] [Related]
93. Genotype 2a hepatitis C virus subgenomic replicon can replicate in HepG2 and IMY-N9 cells.
Date T; Kato T; Miyamoto M; Zhao Z; Yasui K; Mizokami M; Wakita T
J Biol Chem; 2004 May; 279(21):22371-6. PubMed ID: 14990575
[TBL] [Abstract][Full Text] [Related]
94. Green tea phenolic epicatechins inhibit hepatitis C virus replication via cycloxygenase-2 and attenuate virus-induced inflammation.
Lin YT; Wu YH; Tseng CK; Lin CK; Chen WC; Hsu YC; Lee JC
PLoS One; 2013; 8(1):e54466. PubMed ID: 23365670
[TBL] [Abstract][Full Text] [Related]
95. Curcumin inhibits HCV replication by induction of heme oxygenase-1 and suppression of AKT.
Chen MH; Lee MY; Chuang JJ; Li YZ; Ning ST; Chen JC; Liu YW
Int J Mol Med; 2012 Nov; 30(5):1021-8. PubMed ID: 22922731
[TBL] [Abstract][Full Text] [Related]
96. Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection.
Boriskin YS; Pécheur EI; Polyak SJ
Virol J; 2006 Jul; 3():56. PubMed ID: 16854226
[TBL] [Abstract][Full Text] [Related]
97. siRNA-resistance in treated HCV replicon cells is correlated with the development of specific HCV mutations.
Konishi M; Wu CH; Kaito M; Hayashi K; Watanabe S; Adachi Y; Wu GY
J Viral Hepat; 2006 Nov; 13(11):756-61. PubMed ID: 17052275
[TBL] [Abstract][Full Text] [Related]
98. 17,β-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle.
Magri A; Barbaglia MN; Foglia CZ; Boccato E; Burlone ME; Cole S; Giarda P; Grossini E; Patel AH; Minisini R; Pirisi M
Liver Int; 2017 May; 37(5):669-677. PubMed ID: 27885811
[TBL] [Abstract][Full Text] [Related]
99. Anti-bovine viral diarrhoea virus and hepatitis C virus activity of the cyclooxygenase inhibitor SC-560.
Okamoto M; Sakai M; Goto Y; Salim MT; Baba C; Goto K; Watashi K; Shimotohno K; Baba M
Antivir Chem Chemother; 2009 Sep; 20(1):47-54. PubMed ID: 19794231
[TBL] [Abstract][Full Text] [Related]
100. Analysis of the 5' end structure of HCV subgenomic RNA replicated in a Huh7 cell line.
Takahashi H; Yamaji M; Hosaka M; Kishine H; Hijikata M; Shimotohno K
Intervirology; 2005; 48(2-3):104-11. PubMed ID: 15812182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
